Sol-gel technologies to present at the h.c. wainwright autoimmune & inflammatory disease virtual conference

Ness ziona, israel, march 20, 2023 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a dermatology company with two innovative dermatology products that were launched in the u.s. and an innovative pipeline, today announced that it will present at h.c. wainwright's autoimmune & inflammatory disease virtual event on thursday, march 30, 2023.

SLGL Ratings Summary

SLGL Quant Ranking